Fritextsökning
Innehållstyper
-
Q-linea ska spara – fackliga förhandlingar inledda
Uppsalabolaget Q-linea ska minska sina operativa kostnader med tio procent. Samtidigt omfördelas resurser från utveckling till kommersiella aktiviteter, med tonvikt på USA.
-
Roche breddar användningen av sitt tidigare cancerläkemedel
Roche har fått FDA-godkännande för att använda sitt läkemedel Gazyva vid behandling av vuxna med aktiv lupusnefrit – en allvarlig njurkomplikation vid SLE. Besk...
-
Trumps nya sajt ska pressa läkemedelspriser – experter tveksamma
President Donald Trump har lanserat TrumpRx.gov, den nya webbplats han i månader hävdat ska ge amerikaner tillgång till rabatterade receptläkemedel.
-
Varmt välkommen till vår monter på EURO EXPO i Lund
Vi ställer ut på EURO EXPO IndustriMässor Lund den 16-17 oktober och ser fram emot att få träffa dig!
-
Obesity dominates as future blockbusters are identified
Two drug candidates targeting obesity and diabetes stand out sharply in Clarivate’s newly selected “starting eleven” of potential future blockbusters worth watching.
-
AI-genererad psoriasiskandidat lyckades i fas III – kan bli guldklimp för Takeda
En ny behandling för psoriasis klarade målen i sen klinisk fas, och ser ut att ha potential att bli en kommande storsäljare.
-
A new life science cluster formed – “We are very strong in talent”
Stockholm and Uppsala’s joint life science cluster aims to be among the best in Europe. Pontus Holm, Life Science Coordinator for Region Stockholm, says the dec...
-
Radioactive tracer to measure effect of drug towards Crohn’s disease
A radioactive tracer developed by Astra Zeneca and the Karolinska Institutet may play a major role for patients with Crohn's disease. That is the belief of Mari...
-
Ingrid Lönnstedt: Demystification of the power of a scientific study
”You surely do realize that even the smallest changes in study assumptions may influence the estimated sample size needed. And how is it even possible to guess ...
-
Fetma dominerar när kommande blockbusters pekas ut
Två läkemedelskandidater inom fetma och diabetes sticker ut rejält när analysbolaget Clarivate väljer ut sin ”elva” av potentiella framtida storsäljare att hålla ögonen på.
-
Confidence in childhood vaccines is in decline worldwide
Since the pandemic, confidence in vaccinating children has plummeted. In a new report, UNICEF urges world leaders to act before the situation worsens. In 52 out...
-
Vaccinprojekt mot medfödd infektion skrotas i sen fas – ”Klart besvikna”
Hoppet om det första vaccinet mot världens vanligaste medfödda infektion har fått sig en rejäl törn.
-
Specific proposals and targets top the universities’ desired priorities
What are the universities’ expectations for the update of the national life science strategy? Life Science Sweden posed the question to representatives from Kar...
-
Samuel Lagercrantz: ”Will the Swedish life science strategy be updated with precision?”
What will the Swedish government focus on in the life science strategy that is being updated? And what should be prioritized in the strategy? Life Science Swede...
-
The Swedish Academy of Sciences: “We have too many researchers”
Sweden does not need more researchers, but it does need better ones. According to the Royal Swedish Academy of Sciences, funding should be distributed to favour excellence.
-
Marie Gårdmark: ”Interchangeable biological medicines – soon in a pharmacy near you?”
”Generic competition is an effective way to push down drug prices, but it has not worked equally well for biosimilars. Biosimilars require more time to gain mar...
-
Så många toppforskare har Sverige rekryterat från USA
Förra året initierade regeringen en satsning på att locka framstående forskare till Sverige, med siktet inställt på amerikanska akademiker. När året summeras st...
-
Biosimilars bring price pressure, but are they sufficiently used?
When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...
-
Elicera develops CAR-T against solid tumours – may become the first in the world
Today, there are five EU-approved CAR-T therapies, all focused on different types of blood cancer, but no one has yet succeeded in making the method work agains...
-
Claims of life science companies fleeing abroad is a myth according to survey
The claim that life science companies are moving abroad is exaggerated. In fact, only a tiny percentage is leaving the country, according to a survey.
-
Samuel Lagercrantz: The government’s performance in healthcare and life sciences so far
Since the change of government in Sweden, developments in the healthcare sector have shown promising signs, but the outlook in life sciences is less promising, ...
-
The Swedish Research Council gets go-ahead for more long-term funding
Following a government decision, the Swedish Research Council will soon be able to approve ten-year grant periods for funding research infrastructure, which may affect the giant Max IV project, among others....
-
Rostfria lösningar med precision från Schwer Fittings
OEM Automatic erbjuder ett komplett sortiment av kopplingar, ventiler och rör i rostfritt stål från Schwer Fittings – en ledande europeisk tillverkare känd för ...
-
"Unclear proposal from the EU Commission on how to solve the MDR challenges"
Even before the EU regulation on medical devices (MDR) came into force, medical technology companies and doctors were concerned that it would endanger the avail...
BREAKING